Comparison between Rasona Ksheerapaka and Clomiphene Citrate in the treatment of infertility due to anovulation

Evaluation of comparative efficacy of Rasona Ksheerapaka versus Clomiphene Citrate in the management of anovulation induced infertility - RCT - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/10/075753

Enrollment

Registered

2024-10-23

Start date

Unknown

Completion date

Unknown

Last updated

2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N970- Female infertility associated withanovulation

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patients of primary or secondary infertility due to anovulation or delayed ovulation 2 Patients having PCOD (Hyperandrogenic ovulatory dysfunction) 3 Irregular or scanty menses due to anovulatory cycle

Exclusion criteria

Exclusion criteria: ? Unmarried patients non-fertile age group patients ? Bleeding P/V ? Carcinoma of cervix, Vaginal polypoid growth ? Diagnosed patients of fibroids in uterus ? Inborn genital tract abnormality ? Endometritis due to tubercular infection ? HIV/VDRL/HbsAg positive ? Diagnosed subjects for malignancy ? Patients on hormonal treatment ? Non-Cooperative patients

Design outcomes

Primary

Measure	Time frame
To evaluate the ovulatory effects of trial drug To predict possible mode of action of trial drug on anovulatory menstrual cycle Timepoint: 120 days	—

Secondary

Measure	Time frame
To provide herbal cost effective better alternative in the management of anovulation in the patients of infertility To observe adverse drug reactions of trial drug if any during the trial & follow up period Timepoint: 120 days	—

Countries

India

Contacts

Public ContactDR Varsha P Jadhao

MGACHRC, Salod, Wardha, Maharastra

drvarshapadhav@gmail.com9762780280

Outcome results